Marketable Securities, Current in USD of BioRestorative Therapies, Inc. from Q3 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
BioRestorative Therapies, Inc. quarterly Marketable Securities, Current history and change rate from Q3 2022 to Q3 2025.
  • BioRestorative Therapies, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $3,887,383, a 66.5% decline year-over-year.
Source SEC data
View on sec.gov
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

BioRestorative Therapies, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,887,383 -$7,711,034 -66.5% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $5,825,685 -$6,602,533 -53.1% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $7,884,132 -$7,377,088 -48.3% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $10,184,701 +$3,083 +0.03% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $11,598,417 +$1,796,580 +18.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $12,428,218 +$2,596,499 +26.4% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $15,261,220 +$4,723,640 +44.8% 31 Mar 2024 10-Q 11 Jun 2024 2024 Q1
Q4 2023 $10,181,618 -$2,854,018 -21.9% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $9,801,837 -$111,830 -1.13% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $9,831,719 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $10,537,580 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $13,035,636 31 Dec 2022 10-K/A 11 Jun 2024 2023 FY
Q3 2022 $9,913,667 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.